Study Reveals How Price Controls Harmed Biopharma Industry in Europe

Europe has long taken a stricter regulatory approach to the Pharmaceutical industry than the U.S. Nowhere is this more apparent than in the area of price controls. Europe has been zealous in its application of price-caps on prescription medicines in an effort to hold down drug prices. Unfortunately, these policies frequently lead to sharp declines […]

Drug Price Controls on Drugs Will Cost Patients

President Biden’s and Congressional Democrats’ Build Back Better Act attempts to lower prescription drug prices. The act includes new measures that seek to dramatically limit the costs of prescription drugs in the United States by giving government agencies immense control over setting prices. Also included are measures that would require insurance providers to pay a […]

Podcast on Drug Pricing Reform: Good Ideas and Bad Ideas — with Dr. Robert Popovian

Description:  Rising drug prices continue to be a top concern for Americans. In response, members of Congress are floating multiple recycled ideas that revolve around price controls. In this episode, Dr. Robert Popovian, the Founder of the strategic consulting firm Conquest Advisors, Senior Health Policy Fellow at the Progressive Policy Institute, and previously the Vice […]

The Economic Standard: IPI Model Will Cause Shortage of Life-Saving Drugs

Access to life-saving treatments makes a tremendous difference in the lives of Medicare patients. We cannot expect to copy the price models of other nations without inheriting the grueling flaws that come with these price controls. Hopefully, for the sake of consumers, President Biden’s administration will reverse Trump on this. The entire piece is available […]

The Big Problem with Price Controls: Scarcity

One of the most pressing problems facing Americans and the U.S. healthcare system is the affordability of prescription drugs. An estimated 58 million Americans face medication insecurity and have “been unable to afford prescribed drugs at least once in the last 12 months.” The Organization for Economic Co-Operation and Development claimed that per capita, Americans pay $1,220 per year […]

Real Clear Health: Rx Price Transparency Is Key to Lowering Health Care Costs

The Trump administration’s recent efforts to increase transparency in hospital pricing have expectedly been met with legal push-back from the hospitals themselves. But shadowy hospital pricing is just the tip of the opaque iceberg that is driving up the costs of health care in America. To inject more competition into the industry, Congress and the […]

Capital Hill Event: Drug Pricing Policy Prescriptions for 2020

On September 25, 2019, the American Consumer Institute held a policy briefing called “Pricing Policy Prescriptions for 2020: The Good, The Bad, and The Ugly.” The event included guest speaker John Fund, along with the following policy experts: Krisztina Pusok, Director of Policy and Research at the American Consumer Institute (moderating); Robert Graboyes is a Senior […]